Professor David Price
Chair of Primary Care Respiratory Med
- About
-
- Email Address
- d.price@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437237
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Publications
-
Page 47 of 93 Results 461 to 470 of 923
Lack of asthma and rhinitis control in general practitioner-managed patients prescribed fixed-dose combination therapy in Australia
Journal of Asthma, vol. 55, no. 6, pp. 684-694Contributions to Journals: ArticlesManagement of allergic rhinitis in the community pharmacy: identifying the reasons behind medication self-selection
Pharmacy Practice , vol. 16, no. 3, pp. 1-8Contributions to Journals: ArticlesMatching Inhaler Devices with Patients: The Role of the Primary Care Physician
Canadian Respiratory Journal, vol. 2018, 9473051Contributions to Journals: Review articles- [ONLINE] DOI: https://doi.org/10.1155/2018/9473051
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/c5b74d4b-cc9d-4113-92e8-d482f9a53e68/download
- [ONLINE] View publication in Scopus
Performance of database-derived severe exacerbations and asthma control measures in asthma: responsiveness and predictive utility in a UK primary care database with linked questionnaire data
Pragmatic and Observational Research, vol. 2018, no. 9, pp. 29-42Contributions to Journals: ArticlesIdentifying the hidden burden of allergic rhinitis (AR) in community pharmacy: a global phenomenon
Asthma Research and Practice, vol. 3, 8Contributions to Journals: ArticlesP198 Feno and blood eosinophils as biomarkers in predicting asthma exacerbations
Thorax, vol. 72, no. Suppl 3, pp. A190Contributions to Journals: AbstractsP203 A comparison of adverse events associated with licensed and unlicensed spacer use with non-extrafine beclometasone dipropionate treatment in a real-life patient population with asthma in the uk
Thorax, vol. 72, no. Suppl 3, pp. A193Contributions to Journals: AbstractsP274 Comparison of the initiation of copd treatment with licensed fdc ics/laba treatments in terms of disease control and cost effectiveness
Thorax, vol. 72, no. Suppl 3, pp. A232Contributions to Journals: AbstractsRedefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease
Journal of the American Medical Directors Association, vol. 18, no. 12, pp. 1097.e11-1097.e24Contributions to Journals: ArticlesThe effect of DPP-4 inhibitors on asthma control: an administrative database study to evaluate a potential pathophysiological relationship
Pragmatic and Observational Research, vol. 2017, no. 8, pp. 231-240Contributions to Journals: Articles